Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy

BACKGROUND: Hepatitis C virus roots a chronic liver disease. Currently approved treatment strategy includes administration of alpha interferon and ribavirin combined therapy for 24-48 weeks. One of the predictor of sustained virological response is an early virological response to treatment characte...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Akram, Madiha, Idrees, Muhammad, Hussain, Abrar, Afzal, Samia, Ilyas, Muhammad, Zafar, Shamail, Aftab, Mahwish, Badar, Sadaf, Khubaib, Bushra
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117844/
https://ncbi.nlm.nih.gov/pubmed/21605410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-253
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares